Kiiski, Ville <br/><br/>
Long-term safety of topical pimecrolimus and topical tacrolimus in atopic blepharoconjunctivitis.  [electronic resource] 

 -  JAMA dermatology  May 2014 
 - 571-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2168-6084 
<br/><br/><label>Standard No.: </label>10.1001/jamadermatol.2013.7016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Adult<br/>Blepharitis--complications<br/>Cohort Studies<br/>Conjunctivitis, Allergic--complications<br/>Databases, Factual<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Finland<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Patient Safety<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Tacrolimus--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult